Plain-English translation of NCT06436053 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Heart Failure research guide →This trial is testing a pacemaker system called SyncAV, which includes a special feature that automatically adjusts the timing between your heart's upper and lower chambers. The study focuses on people who have heart failure and a specific type of electrical delay in their heartbeat called left bundle branch block or similar conduction delays. Researchers want to see whether this automatic timing adjustment helps improve how well the pacemaker works for you.
Heart failure patients often have electrical problems that make their heart chambers beat out of sync, which weakens the heart's pumping power. This new automatic timing feature is designed to help coordinate those beats more effectively, and doctors want to confirm it actually works well in real patients.
You likely qualify if…
You likely don't qualify if…
You would receive an Abbott pacemaker implant with the SyncAV feature during a surgical procedure. After implantation, the research team would monitor how well the automatic timing adjustment works during follow-up visits. The study involves a single center and is designed to gather information about how your heart responds to this new pacemaker feature in the short term.
AI-generated summary from trial data · Jul 12, 2026 · Not medical advice
Italy
Sponsor
Abbott Medical Devices
Enrollment target
~50 participants
Started
May 2024
Primary completion
December 2026
Age range
18 Years and older
Last updated on clinicaltrials.gov in July 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Nima Badie, PhD
Abbott Medical Devices
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.